Lee Financial’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-115
Closed -$4.85K 863
2023
Q2
$4.85K Hold
115
﹤0.01% 515
2023
Q1
$4.1K Sell
115
-115
-50% -$4.17K ﹤0.01% 559
2022
Q4
$8.44K Sell
230
-100
-30% -$3.95K ﹤0.01% 487
2022
Q3
$15K Sell
330
-23
-7% -$1.49K ﹤0.01% 374
2022
Q2
$25K Buy
353
+2
+0.6% +$146 ﹤0.01% 313
2022
Q1
$28K Sell
351
-45
-11% -$3.81K 0.01% 297
2021
Q4
$41K Hold
396
0.01% 275
2021
Q3
$35K Buy
396
+115
+41% +$10.4K 0.01% 264
2021
Q2
$25K Buy
281
+16
+6% +$1.35K 0.01% 296
2021
Q1
$20K Hold
265
﹤0.01% 312
2020
Q4
$18K Buy
265
+65
+33% +$4.05K ﹤0.01% 310
2020
Q3
$11K Buy
200
+40
+25% +$2.38K ﹤0.01% 394
2020
Q2
$9K Buy
+160
New +$8.6K ﹤0.01% 390

Other funds holding SYNH

Lee Financial's SYNH Position: Q3 2023 in Review

Lee Financial sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 115 shares — an estimated $4.85K sold.

Lee Financial first reported a position in SYNH in Q2 2020 and held it in 13 quarters. The position peaked at $41K in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Lee Financial reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Lee Financial sold 115 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $4.85K.
  • Lee Financial first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2020 and held it in 13 quarters.
  • Lee Financial's Syneos Health, Inc. Class A Common Stock position peaked at $41K in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Lee Financial's 13F filing for Q3 2023, filed 9 Nov 2023.